Tennis: Murray falls to Korda in Gijon Open quarter-finals | ABS-CBN

ABS-CBN Ball 2025:
|

ADVERTISEMENT

ABS-CBN Ball 2025:
|
dpo-dps-seal
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!

Tennis: Murray falls to Korda in Gijon Open quarter-finals

Tennis: Murray falls to Korda in Gijon Open quarter-finals

Agence France-Presse

Clipboard

US player Sebastian Korda in action during his quarter final match against Britain
US player Sebastian Korda in action during his quarter final match against Britain's Andy Murray at the Gijon Open tennis tournament in Gijon, Spain, 14 October 2022. EPA-EFE/Eloy Alonso

GIJON, Spain -- Britain's Andy Murray fell to American Sebastian Korda in the Gijon Open quarter-finals on Friday.

Korda, ranked 47, won through 6-4, 1-6, 6-1 against former world number one Murray, now ranked 48, in two hours and 27 minutes.

Wildcard Murray was playing his first tournament since September's Laver Cup, but after rallying in the second set the 35-year-old was unable to maintain the momentum in the third.

Korda, 22, advances to meet France's Arthur Rinderknech who saved nine match points before ousting second seed Pablo Carreno Busta, the last Spaniard in the tournament, 4-6, 6-3, 7-6 (18/16).

ADVERTISEMENT

Rinderknech staved off two match points on serve at 4-5 in the third set, and a further seven in the third-set tie-break, before sealing victory on his sixth match point after just over three-hours in northern Spain.

Earlier Austrian Dominic Thiem continued his quest for his first title since the 2020 US Open when he eased past fourth seed Francisco Cerundolo of Argentina 6-4, 6-3.

The 29-year-old next plays top seed Andrey Rublev who dispatched fifth seeded American Tommy Paul 7-5, 6-3 in 87 minutes.

Rublev, who triumphed in Marseille, Dubai and Belgrade earlier this season, has boosted his chances of qualifying for the ATP Finals.

© Agence France-Presse

ADVERTISEMENT

ADVERTISEMENT

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.